AI and Sequential Organ Failure Assessment

Peach IntelliHealth is a New York based Artificial Intelligence & Machine Learning (AI/ML) healthcare company. Founded by five MIT scientists, their product Peach ACE is used to predict patient trajectory hours before measurable signals. The company was founded in 2013 and has yet to take a major funding round, though it is currently seeking synergistic partners. Peach IntelliHealth recently filed their first patent application for their technology, which could point to a desire to increase valuation in order to bring in capital to scale.